Research & Development
Black Buffalo partners with Sanova to support regulatory strategy and scientific innovation
17 December 2025 - Smokeless tobacco alternatives company Black Buffalo Inc announced on Tuesday that it has partnered with Sanova LLC, a New York-based scientific and regulatory consulting agency, to...
Nicox completes key data package for NCX 470 NDA submissions
16 December 2025 - Ophthalmology company Nicox SA (Euronext Growth Paris:ALCOX) announced on Tuesday that it has completed the generation and analysis of all clinical trial and long-term stability dat...
Immusoft's ISP-002 granted US FDA Orphan Drug Designation in MPS II
16 December 2025 - Clinical-stage biotechnology company Immusoft of CA, a subsidiary of Immusoft Corporation, announced on Monday that it has received Orphan Drug Designation from the US Food and Drug...
Orphan Therapeutics Accelerator signs MoU with Fondazione Telethon
16 December 2025 - Non-profit biotech company Orphan Therapeutics Accelerator (OTXL) announced on Monday that it has signed a Memorandum of Understanding (MoU) with Fondazione Telethon, an Italian non...
Bioretec wins FDA breakthrough status for biodegradable orthopaedic DrillPin
15 December 2025 - Finnish medical device company Bioretec Oy (HEL: BRETEC), which develops biodegradable orthopaedic implants, announced on Sunday that the US Food and Drug Administration had granted...
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
15 December 2025 - Swedish medtech company Amferia, a developer of next-generation antimicrobial wound-care solutions, announced that it has closed an oversubscribed EUR3.5m investment round.The fundi...